Menu

Arthur Kaser

CEO/ CSO & Co-founder

Arthur Kaser

Arthur Kaser is Professor of Gastroenterology at Cambridge University. A brilliant academic gastroenterologist, his research has provided fundamental new insight into the mechanism of inflammatory bowel disease. Through the creation and use of genetically engineered mice Professor Kaser discovered that dysregulation of fundamental cell intrinsic processes in an enterocyte can cause Inflammatory Bowel Disease, and that polymorphisms in the genetic elements that control these processes are associated with an enhanced risk to develop these common illnesses. This discovery, along with others, was reported in the prestigious journal Cell.

Follow

Connect with us to explore opportunities for collaboration and investment.

© 2024 Momentous Therapeutics

Momentous Therapeutics Ltd is registered in England & Wales (Registered number 14150840)

Momentous Therapeutics Ltd

Harston Mill

Royston Rd

Harston

Cambridge CB22 7GG